← Back to Search

Diabetes Prevention Pathway for Prediabetes

N/A

Waitlist Available

Led By Eva Tseng, MD

Research Sponsored by Johns Hopkins University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

PCP visit during intervention period

Age ≥ 18 years

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months

Awards & highlights

Study Summary

This trial will study whether a diabetes prevention clinical pathway can help people with prediabetes.

Who is the study for?

This trial is for adults over 18 with prediabetes who are patients at Johns Hopkins GSS General Internal Medicine or JHCP Internal Medicine clinic and have a primary care physician (PCP) visit during the study period. It's not open to those seeing clinicians other than their PCP.Check my eligibility

What is being tested?

The trial tests a new diabetes prevention clinical pathway designed to overcome barriers faced by doctors and patients, aiming to improve screening, intervention, and patient engagement in preventing diabetes compared to usual care.See study design

What are the potential side effects?

Since this trial involves implementing a clinical pathway rather than testing a drug, it does not have typical medication side effects. However, there may be indirect effects related to changes in lifestyle or stress due to participation.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I will see my primary care provider during the study.

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of participants prescribed metformin

Number of participants referred to Diabetes Prevention Program

Number of participants referred to Medical Nutrition Therapy

Secondary outcome measures

Change in weight

Number of participants enrolled in Diabetes Prevention Program

Medical Nutrition Therapy

+3 more

Trial Design

2Treatment groups

Active Control

Group I: Intervention clinicActive Control1 Intervention

Patients with prediabetes seen for routine care at intervention clinic

Group II: Control clinicActive Control1 Intervention

Patients with prediabetes seen for routine care at control clinic

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH

2,356 Previous Clinical Trials

4,312,666 Total Patients Enrolled

Johns Hopkins UniversityLead Sponsor

2,256 Previous Clinical Trials

14,817,671 Total Patients Enrolled

Eva Tseng, MDPrincipal InvestigatorJohns Hopkins University

1 Previous Clinical Trials

100 Total Patients Enrolled

Media Library

Intervention clinic Clinical Trial Eligibility Overview. Trial Name: NCT05265312 — N/A

Prediabetes Research Study Groups: Intervention clinic, Control clinic

Prediabetes Clinical Trial 2023: Intervention clinic Highlights & Side Effects. Trial Name: NCT05265312 — N/A

Intervention clinic 2023 Treatment Timeline for Medical Study. Trial Name: NCT05265312 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still opportunities for individuals to enroll in this clinical experiment?

"Affirmative. Records hosted on clinicaltrials.gov affirm that this research study, which was first uploaded on May 31st 2022, is presently enrolling participants. Approximately 1200 patients must be recruited from 1 medical facility."

Answered by AI

How many participants is the research team recruiting for this investigation?

"Affirmative. According to the clinical trials portal, this research program is currently seeking participants. This study was first advertised on May 31st 2022 and its parameters were most recently updated on June 1st 2022; 1200 patients are required from one centre."

Answered by AI